Invion (IVX) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock IVX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Invion Limited Releases Holdings AnalysisJuly 17 at 2:27 AM | tipranks.comInvion Opens Entitlement Offer to Boost R&D InitiativesJuly 1, 2025 | tipranks.comInvion Director Increases Stake Through Option ExerciseJune 25, 2025 | tipranks.comInvion Director Alters Securities HoldingsJune 25, 2025 | tipranks.comInvion Explores Expansion of Photosoft™ Technology Rights and Clinical ProgramsJune 24, 2025 | tipranks.comInvion Limited Announces Quotation of New Securities on ASXJune 23, 2025 | tipranks.comInvion Limited Updates Proposed Securities Issue with New OptionsJune 23, 2025 | tipranks.comInvion Limited Announces $1 Million Entitlement OfferJune 22, 2025 | tipranks.comInvion Limited Announces Pro Rata Issue of Loyalty OptionsJune 22, 2025 | tipranks.comInvion Limited Announces Entitlement Offer to Raise $1 MillionJune 22, 2025 | tipranks.comInvion Reports Positive Trial Results for Skin Cancer TreatmentJune 10, 2025 | tipranks.comInvion Unveils New Presentation on Innovative Cancer Treatment TechnologyJune 3, 2025 | tipranks.comInvion Limited Updates Registered Office AddressJune 1, 2025 | tipranks.comInvion Expands Share Issuance and Eyes New Opportunities for Photosoft ™ TechnologyMay 26, 2025 | tipranks.comInvion Limited Announces Quotation of New Securities on ASXMay 26, 2025 | tipranks.comInvion Limited Issues Unquoted Securities to Strengthen Financial PositionMay 26, 2025 | tipranks.comInvion Limited Issues New Unquoted Equity SecuritiesMay 14, 2025 | tipranks.comInvion’s Extraordinary General Meeting Resolutions Successfully PassedMay 8, 2025 | tipranks.comInvion Advances Non-Melanoma Skin Cancer Trial with Successful Initial DosingMay 1, 2025 | tipranks.comInvion Limited Announces Virtual Extraordinary General MeetingApril 7, 2025 | tipranks.comInvion Limited Announces Quotation of New Securities on ASXMarch 12, 2025 | tipranks.comInvion Expands Share Issuance and Explores New Opportunities for Photosoft™ TechnologyMarch 12, 2025 | tipranks.comInvion Limited Updates Securities Issuance StrategyMarch 11, 2025 | tipranks.comInvion raises $2M in share placement to support cancer research workMarch 4, 2025 | msn.comInvion Limited Announces Quotation of New SecuritiesJanuary 23, 2025 | tipranks.comInvion Expands Financial Base and Explores New Opportunities for Photosoft™ TechnologyJanuary 23, 2025 | tipranks.comInvion Expands Shares and Eyes New HorizonsJanuary 1, 2025 | tipranks.comInvion Appoints Renowned Scientist to Boost Cancer ResearchDecember 16, 2024 | markets.businessinsider.comInvion Explores Expansion Amidst New Share IssuanceDecember 16, 2024 | msn.comInvion Limited Updates on Director’s Share OptionsDecember 10, 2024 | tipranks.comInvion Director Acquires Share Options, Aligns InterestsDecember 10, 2024 | tipranks.comInvion Limited Issues Share Options to DirectorDecember 10, 2024 | tipranks.com3 ASX Penny Stocks With Market Caps Over A$20M To WatchDecember 4, 2024 | finance.yahoo.comClosing Bell: ASX gallops as healthcare sector jumps, led by InvionDecember 4, 2024 | msn.comHealth Check: Let there be light (therapy). Invion up 160pc on skin cancer trial newsDecember 3, 2024 | msn.comInvion Begins Promising Skin Cancer Treatment TrialDecember 2, 2024 | tipranks.comInvion Completes Securities Consolidation and Resumes TradingNovember 27, 2024 | tipranks.comInvion Limited Expands Share Issuance and Growth PlansNovember 24, 2024 | tipranks.comInvion Limited’s Annual Meeting Boosts Investor ConfidenceNovember 14, 2024 | markets.businessinsider.comInvion Ltd. Advances in Cancer Therapy InnovationsNovember 14, 2024 | markets.businessinsider.comBiocurious: Invion taps the power of light to zap solid tumoursOctober 29, 2024 | msn.comInvion Limited Reports Promising Cancer Trial ResultsOctober 28, 2024 | msn.comInvion Ltd. Issues 50 Million New Shares on ASXOctober 23, 2024 | markets.businessinsider.comInvion Expands Share Issuance and Eyes Technology RightsOctober 23, 2024 | markets.businessinsider.comHealth Check: Paradigm receives FDA guidance on proposed trial for dodgy kneesSeptember 18, 2024 | msn.comClosing Bell: ASX tracks global selloff; Yancoal and GYG amongst new ASX200 entrantsSeptember 9, 2024 | msn.comAeroVironment’s (NASDAQ:AVAV) Q2 Sales Beat Estimates But Full-Year Sales Guidance Misses ExpectationsSeptember 5, 2024 | theglobeandmail.com1 High-Yield Energy Stock to Buy and HoldAugust 29, 2024 | msn.comASX Small Caps Lunch Wrap: MinRes highlights today’s bourse-based misery as most sectors wallowAugust 29, 2024 | msn.comClosing Bell: Windy day for stocks as ANZ, Tabcorp get stung by regulatorsAugust 23, 2024 | msn.com Get Invion News Delivered to You Automatically Sign up to receive the latest news and ratings for IVX and its competitors with MarketBeat's FREE daily newsletter. Email Address IVX Media Mentions By Week IVX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IVX News Sentiment▼-0.910.59▲Average Medical News Sentiment IVX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IVX Articles This Week▼11▲IVX Articles Average Week Get Invion News Delivered to You Automatically Sign up to receive the latest news and ratings for IVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Voyageur Pharmaceuticals News Today Decibel Cannabis News Today Shield Therapeutics News Today Willow Biosciences News Today MediPharm Labs News Today Charlotte's Web News Today Crescita Therapeutics News Today Celadon Pharmaceuticals News Today Valeo Pharma News Today Merck KGaA News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:IVX) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invion Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Invion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
